Galliford Try PLC (GFRD)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 667.00 |
|---|---|
| 52-week range | 466.00 – 726.81 |
| Return, 1 month / 3 months | −5.3% / +7.9% |
| Return, 1 year / 3 years | +33.3% / +252.9% |
| Trend | Uptrend |
| RSI (14) | 48 |
| Volatility (1 year) | 26.9% |
| Worst drawdown (1 year) | -16.3% |
| Average daily value traded | 201.05M GBX |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Galliford Try is a British construction and housebuilding company based in the United Kingdom. Its construction business works on infrastructure and building projects, including roads, water and energy facilities, for public and private sector clients. The group also develops new homes for sale through its housebuilding operations, serving homebuyers across its regional markets. It carries out building and civil engineering work under contract for customers such as local authorities, utilities and developers.
Galliford Try PLC trades under the code GFRD on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Galliford Try PLC (GFRD) trades on the London Exchange in UK. It last closed at GBX 667.00 on 22 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 32 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.3% and over the last three months it rose 7.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.1% | ||
| From 52-week high | -5.9% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.9% | ||
| 6-month return | 24.9% | ||
| 12-month return, skipping the last month | 40.7% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.3% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 201.05M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −5.3% |
| 3 months | +7.9% |
| 6 months | +24.9% |
| 1 year | +33.3% |
| 3 years | +252.9% |
| 5 years | +359.6% |
Signals
| 50-day / 200-day average | 646.66 / 564.98 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 21.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Nov 2026 | GBP 0.1700 |
| 12 Mar 2026 | GBP 0.0650 |
| 6 Nov 2025 | GBP 0.1350 |
| 13 Mar 2025 | GBP 0.0550 |
| 7 Nov 2024 | GBP 0.1150 |
| 14 Mar 2024 | GBP 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.